Pulled from some seminar materials I am developing, and based on recent interactions with hundreds of executives, financial officers and providers:
Problems with Obamacare (and
related)
#1 by a huge margin in non-scientific
poll of hundreds of providers: deferral of care due to larger
co-payments (premium share, co-pay, deductible)
a weak labor market combined with ACA
impacts on insurers = massive risk shift to employees
insurers reacting to ACA, employers
reacting to ACA, shifting costs to working middle class
immense shift in bargaining power in
insurer vs. provider balance
THIS COULD BE A MAJOR HINDRANCE TO
PREVENTIVE CARE
STRATEGIES
mid sized employers confused and
beleaguered
chaos in the hospital sector (due to
ratchet down of revenues and scramble for business models)
mad scramble to integrate and build new
business models, often fueled by massive uncertainty
ACOs not delivering yet at any large
scale
failure to properly implement the back end of
healthcare.gov
hundreds of thousands of families may
have to repay due to flawed
subsidy calcs
providers cannot get easily or timely
get coverage information, but on the hook
major problems with EMR/EHR
implementation, “meaningful use” a mess
DHHS-CMS late with regulations (compliance), or writing incoherent regulations (meaningful use)
family practice not better off and
often worse off
nothing significant to boost supply of
family docs or nurses
(will we see a boomer provider
retirement surge? Stay tuned)
Medicaid fees with small contribution
margins (variable costing) and negative contribution margins (full
costing)
C.L.A.S.S. was stillborn and long-term
care funding is being ignored at our peril
readmission penalties – first stage
of formal rationing?
future of rural health care in doubt
(small hospitals are probably toast within 5 years), small
improvement in urban health care access (the hospital shake out will
impact the outcome)
ACA based innovations
access improved
somewhat and screening procedures in place (although someone has to
pay)
surge of integration and construction
of new business models (for better and worse).
ACO trials are in progress, could yield
scaled results in the future
surge of innovation in business models
bundling could provide major benefits
surge of innovation in analytics (the
government is not much help)
surge of innovation in clinical care
more careful use of ordering (imaging,
Rx, therapies) but could have a clinical downside
FINALLY, providers have significant
negotiating leverage in dealing with some suppliers